LEADER 01888nam 2200469 450 001 9910465250103321 005 20200520144314.0 010 $a3-86945-918-2 035 $a(CKB)3710000000736711 035 $a(EBL)4571938 035 $a(MiAaPQ)EBC4571938 035 $a(Au-PeEL)EBL4571938 035 $a(CaPaEBR)ebr11243154 035 $a(CaONFJC)MIL933948 035 $a(OCoLC)952154556 035 $a(EXLCZ)993710000000736711 100 $a20160907h20162016 uy 0 101 0 $ager 135 $aur|n|---||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aSpektrum Iran $eZeitschrift fu?r Islamisch-Iranische Kultur : Kultur - Wissenschaft - Forschung 210 1$aNordhausen, [Germany] :$cVerlag Traugott Bautz GmbH,$d[2016] 210 4$dİ[2016] 215 $a1 online resource (109 p.) 225 1 $aSPEKTRUM IRAN ;$vv.2 300 $aDescription based upon print version of record. 311 $a3-95948-130-6 327 $aCover ; Titelei ; Impressum ; Inhalt; Liebe Leserinnen, liebe Leser!; Einleitung; Die Facetten menschlicher Identita?t und der Erwerb von Fa?higkeiten - von Regine Kather ; Mensch und Identita?t. Gefa?hrdung der Identita?t in ihrer Bedeutung fu?r den Menschen - von Peter Gerdsen ; Der Weg zur eigenen Identita?t. Ein lebenslanger Lernprozess - von Philipp Thull ; Logik und Hermeneutik der Identita?t in einer vera?nderten Welt - von Hamid Reza Yousefi ; Einfluss der Literatur auf Grenzgestaltung und Umwandlung der allgemeinen Identita?t - von Mehrdad Akbari Gandomani 410 0$aSPEKTRUM IRAN 606 $aIslam$zIran 608 $aElectronic books. 615 0$aIslam 676 $a181.5 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910465250103321 996 $aSpektrum Iran$91320860 997 $aUNINA LEADER 05221nam 2200649Ia 450 001 9910454160603321 005 20200520144314.0 010 $a1-281-89267-X 010 $a9786611892678 010 $a1-84642-860-2 035 $a(CKB)1000000000702702 035 $a(EBL)412857 035 $a(OCoLC)437090048 035 $a(SSID)ssj0000138787 035 $a(PQKBManifestationID)11129921 035 $a(PQKBTitleCode)TC0000138787 035 $a(PQKBWorkID)10101887 035 $a(PQKB)10121890 035 $a(MiAaPQ)EBC412857 035 $a(Au-PeEL)EBL412857 035 $a(CaPaEBR)ebr10264095 035 $a(CaONFJC)MIL189267 035 $a(EXLCZ)991000000000702702 100 $a20080623d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aDietary interventions in autism spectrum disorders$b[electronic resource] $ewhy they work when they do, why they don't when they don't /$fKenneth J. Aitken 210 $aLondon ;$aPhiladelphia $cJessica Kingsley Publishers$d2009 215 $a1 online resource (274 p.) 300 $aDescription based upon print version of record. 311 $a1-84310-939-5 320 $aIncludes bibliographical references (p. 242-263) and index. 320 $a"A bibliography of some of the best-known books on low-carbohydrate diets": p. 239-241. 327 $aFRONT COVER; DIETARY INTERVENTIONS IN AUTISM SPECTRUM DISORDERS; Why They Work When They Do, Why They Don't When They Don't; Contents; HOW TO USE THIS BOOK; PART I DIETS, ASDS AND DIETARY INTERVENTIONS; 1. Introduction to Dietand ASDs; Why do we eat what we do?; Autism spectrum disorders; Preliminary conclusion - more research needs to be done; Families use dietary interventions whatever the clinical recommendations or admonitions; So where do we go from here?; 2. Dietary Interventions; Why would you think of using a diet to help someone with an ASD? 327 $aThings to leave out which may be causing a problemDigestive differences; An overview of toxic reactions; Potentially protective factors; Aberrant immune responses; Difficulties with body clearance; PART II DIETS FOR PEOPLE WITH ASDS; 3. So, What Diets Are Currently Used with ASDs and Why?; 4. The Mackarness (Low-Carbohydrate, High-Protein) Diet; What are the different types of dietary fats and why is this important?; Why are differences in omega-3and omega-6 levels important?; What is the Mackarness diet?; What does it claim to do?; What is the evidence?; Ketogenics 327 $aIs there evidence of possible problems on low-carbohydrate, high-protein diets?Is there counter-evidence that low-carbohydrate, high-protein diets are less effective?; In summary; What is the relevance today?; Resources; 5. The Feingold Diet; What is it?; What does it claim to do?; What is the evidence?; Does it work?; Is there any evidence of possible problems?; The 'Failsafe' diet; Resources; 6. The Specific Carbohydrate Diet; What is it?; What does it claim to do?; SCD diet protocol; Are there practical difficulties with following the SCD?; What is the evidence? 327 $aIs there any evidence of possible problems?Resources; 7. The CF-GF Diet; What is it?; What is casein?; What is gluten?; What does a CF-GF dietclaim to do?; Is this the same mechanism that causes celiac disease?; What is the evidence for CF-GFdiets in ASD?; Does it work?; Are there potential problems with adopting a CF-GF diet?; Could digestive enzymes be helpful?; Resources; 8. The Low Oxalate Diet; Why do I need to know about oxalates?; What are oxalates?; What is hyperoxaluria?; How is oxalate metabolized?; Can oxalate levels be tested?; What do oxalates do? 327 $aThe low oxalate diet in ASD -what does it aim to do?What is the evidence?; Resources; 9. The Low Glutamate Diet/GARD (Glutamate-Aspartate Restricted Diet); What is it?; What does the diet claim to do?; What is the evidence?; Resources; 10. The Low Phenylalanine Diet; What is it?; What does it claim to do?; What is required?; What is the evidence?; Carnitine; Are there developments in the management of difficulties with phenylalanine metabolism?; Resources; 11. The Low Phenol Diet; What is it?; What does it claim to do?; What is the evidence? 327 $aAre there any potential problems with low phenol diets? 330 $aThe author explores dietary approaches that have been advocated in ASD. For each approach, he explores the potential benefits; evidence for and against the diet; and sources of further information. He describes his own approach, the Simple Restriction Diet (SRD) explaining how to implement it and work out whether a dietary approach is of benefit. 606 $aAutism$xDiet therapy 606 $aDevelopmental disabilities$xTreatment 608 $aElectronic books. 615 0$aAutism$xDiet therapy. 615 0$aDevelopmental disabilities$xTreatment. 676 $a616.858820654 700 $aAitken$b Kenneth J$0936450 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910454160603321 996 $aDietary interventions in autism spectrum disorders$92136873 997 $aUNINA LEADER 05500nam 2200673 450 001 9910809457303321 005 20230807210355.0 010 $a1-118-64058-6 010 $a1-118-64056-X 035 $a(CKB)2670000000613905 035 $a(EBL)2036180 035 $a(SSID)ssj0001498010 035 $a(PQKBManifestationID)11874268 035 $a(PQKBTitleCode)TC0001498010 035 $a(PQKBWorkID)11501893 035 $a(PQKB)10689740 035 $a(MiAaPQ)EBC3059102 035 $a(MiAaPQ)EBC2036180 035 $a(DLC) 2015005256 035 $a(Au-PeEL)EBL3059102 035 $a(CaPaEBR)ebr11050662 035 $a(CaONFJC)MIL778968 035 $a(OCoLC)922954958 035 $a(EXLCZ)992670000000613905 100 $a20150202d2015 uy| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aOveractive bladder $epractical management /$fedited by Jacques Corcos, Scott MacDiarmid, John Heesakkers 210 1$aChichester, West Sussex, United Kingdom ;$aHoboken, New Jersey :$cJohn Wiley & Sons,$d2015. 215 $a1 online resource (272 p.) 300 $aDescription based upon print version of record. 311 $a1-118-64059-4 311 $a1-118-64061-6 320 $aIncludes bibliographical references and index. 327 $aTitle Page; Copyright Page; Contents; Contributors; Foreword; Foreword: The impact of Overactive Bladder on Urogynecology; Foreword; Preface; Section 1 Introduction; Chapter 1 Overactive bladder: terminology and problem spectrum; References; Chapter 2 Pathophysiology; Introduction; The innervation of the bladder; The genesis of the NDO: three hypothesis; The link to the clinic; The neurological pathologies responsible for the development of the neurogenic bladder; Histological changes; Conclusions; References; Section 2 Evaluation; Chapter 3 Timing for evaluation; Conclusion; References 327 $aChapter 4 Clinical evaluation Introduction; History; Neurological history; General gynecological history; Obstetric history; Other relevant past medical and surgical history; Drug history; Examination; Questionnaires and quality of life; Summary; References; Chapter 5 Urodynamic evaluation of the overactive bladder; Introduction; OAB and urodynamics; Filling cystometry and OAB; Cystometrogram; Does OAB equal urodynamic DO? A clinical correlation; Pressure-flow studies and OAB; Summary; References; Chapter 6 Other testing; Bladder/detrusor wall thickness; Biomarkers; Near infrared spectroscopy 327 $aBladder wall strain imaging Autonomic nervous system; Functional brain imaging; Conclusions; References; Section 3 First Line Management; Chapter 7 Changes in lifestyle; Introduction; Lifestyle modifications; Obesity; Smoking; Extremes of daily fluid intake; Dietary bladder irritants; Constipation and straining at stool; Summary; References; Patient Guide 1 Lifestyle changes that can improve bladder symptoms; Maintain a healthy weight; Stop smoking; Moderate liquid and beverage intake; Monitor your diet; Maintain bowel regularity; Chapter 8 Physical therapy; Physical therapy 327 $aScheduled voiding/bladder training Pelvic floor muscle training; Electrical stimulation; References; Section 4 Second Line Management; Chapter 9 Oral medication for overactive bladder; Introduction; Antimuscarinics; Beta 3 (?3) adrenergic receptor (AR) agonists; Antidepressants; References; Chapter 10 Patches and gels; Rationale for TD OXY delivery; Drug pharmacology; Conclusion/expert opinion; References; Chapter 11 Promising experimental drugs and drug targets; Introduction; P2X3-receptors and P2X3 receptor antagonists; The cannabinoid system; TRP channels; References 327 $aChapter 12 The role of co-medication in the treatment of OAB Introduction; Antimuscarinics and ?-adrenoreceptor antagonists; Phosphodiesterase-5 inhibitors and ?-adrenoreceptor antagonists; Other combination regimens; Future directions; References; Chapter 13 Other non-surgical approaches for the treatment of overactive bladder; Introduction; Bladder training; Acupuncture; Naturopathic and herbal remedies; Magnetic stimulation; Containment products; Future: tissue engineering and gene therapy; Conclusion; Abbreviations; Financial and competing interests disclosure; References 327 $aSection 5 Third Line Management 330 $aOveractive Bladder: Practical Management provides urologists, gynecologists and other health practitioners with a comprehensive clinical guide to this very common problem, resulting in a perfect resource to consult time and time again. Beginning with an introductory section covering the definition and pathophysiolgy of OAB, it then moves on to cover evaluation, first-line management, second-line management and finally surgery. Well-illustrated throughout, each chapter begins with a key points box outlining the most important take-home messages. Also included are clear management algorithms 606 $aUrinary incontinence$xTreatment 606 $aBladder$xDiseases$xTreatment 615 0$aUrinary incontinence$xTreatment. 615 0$aBladder$xDiseases$xTreatment. 676 $a616.6/2 702 $aCorcos$b Jacques 702 $aMacDiarmid$b Scott A. 702 $aHeesakkers$b John 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910809457303321 996 $aOveractive bladder$94034726 997 $aUNINA LEADER 01528nam 2200469 450 001 9910821873003321 005 20230807213042.0 035 $a(CKB)3710000000929268 035 $a(Au-PeEL)EBL4458776 035 $a(CaPaEBR)ebr11294739 035 $a(CaONFJC)MIL968696 035 $a(OCoLC)962449223 035 $a(MiAaPQ)EBC4458776 035 $a(EXLCZ)993710000000929268 100 $a20161115h20152015 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aWastewater treatment plant design and operation modifications to improve management of biosolids $eregrowth, odors, and sudden increase in indicator organisms /$fby Matthew J. Higgins, Sudhir N. Murthy 210 1$aAlexandria, Virginia :$cWERF,$d2015. 210 4$dİ2015 215 $a1 online resource (150 pages) $cillustrations, graphs 311 $a1-78040-457-3 320 $aIncludes bibliographical references. 606 $aSewage 606 $aSewage disposal plants 606 $aSewage sludge 615 0$aSewage. 615 0$aSewage disposal plants. 615 0$aSewage sludge. 676 $a628.1683 700 $aHiggins$b Matthew J.$0120909 702 $aMurthy$b Sudhir N. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910821873003321 996 $aWastewater treatment plant design and operation modifications to improve management of biosolids$94121678 997 $aUNINA